StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Elutia's pe ratio was 0.8× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×–

More Elutia figures

See a number that looks wrong?